1. Analyst View
2. Research Methodology
3. Key Industry Trends and Drivers
3.1 Technological Transformations Propelling Bioinformatics Market
3.2 Rising Inclination of Pharma Companies towards Bioinformatics
3.3 Cross Border Collaborations to Nurture Bioinformatics Research
3.4 Bioinformatics: Reinvention with Big Data Applications
4. Bioinformatics Market Outlook to 2019
4.1 By Segment
4.1.1 Data Analysis and Software
4.1.1.1 Molecular Dynamics Software
4.1.1.2 Molecular Modeling Software
4.1.1.3 Open Source Bioinformatics Software
4.1.1.4 Data Analysis
4.1.2 Tools and Database Services
4.1.2.1 Generalized Databases
4.1.2.2 Specialized Databases
4.1.3 IT Infrastructure
4.1.3.1 By Segment
4.2 By Region
4.3 By Application
4.3.1 Genomics
4.3.2 Proteomics
4.3.3 Cheminformatics
4.3.4 Transcriptomics
4.3.5 Metabolomics
4.3.6 Molecular Phylogenetics
5. Country Level Analysis
5.1 US
5.2 Canada
5.3 UK
5.4 Germany
5.5 Japan
5.6 India
5.7 China
5.8 South Korea
5.9 Taiwan
5.10 Singapore
5.11 Australia
5.12 Israel
6. Commercialized Products and Services
7. Key Players
7.1 Agilent Technologies, Inc.
7.1.1 Business Description
7.1.2 Financials
7.1.3 Key Strategic Initiatives
7.2 Life Technologies Corporation
7.2.1 Business Description
7.2.2 Financials
7.2.3 Key Strategic Initiatives
7.3 Affymetrix, Inc.
7.3.1 Business Description
7.3.2 Financials
7.3.3 Key Strategic Initiatives
7.4 Accelrys, Inc.
7.4.1 Business Description
7.4.2 Financials
7.4.3 Key Strategic Initiatives
7.5 Illumina Inc.
7.5.1 Business Description
7.5.2 Financials
7.5.3 Key Strategic Initiatives
7.6 ID Business Solutions Ltd
7.6.1 Business Description
7.6.2 Financials
7.6.3 Key Strategic Initiatives
7.7 NonLinear Dynamics Ltd.
7.7.1 Business Description
7.7.2 Financials
7.7.3 Key Strategic Initiatives
7.8 CLC Bio A/S
7.8.1 Business Description
7.8.2 Financials
7.8.3 Key Strategic Initiatives
7.9 Genologics Life Sciences Software, Inc
7.9.1 Business Description
7.9.2 Financials
7.9.3 Key Strategic Initiatives
7.10 Geneva Bioinformatics (Genebio) SA
7.10.1 Business Description
7.10.2 Financials
7.10.3 Key Strategic Initiatives
7.11 Biodiscovery, Inc.
7.11.1 Business Description
7.11.2 Financials
7.11.3 Key Strategic Initiatives
7.12 Kinexus Bioinformatics Corporation
7.12.1 Business Description
7.12.2 Financials
7.12.3 Key Strategic Initiatives